Home > Insider Trading > Filing (0001225208-18-001321)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
310158	Merck & Co. Inc.	MRK	Pharmaceutical Preparations (2834)	221918501

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1168014	M Mirian Weir Graddick	Merck &Amp; Co., Inc. 2000 Galloping Hill Road Kenilworth NJ 07033	Exe V-P, Hr	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Disposition	2018-01-12	8,000	$58.00	98,484	No	4	S	Direct
Common Stock	Acquisiton	2018-01-16	52,000	$44.30	150,484	No	4	M	Direct
Common Stock	Disposition	2018-01-16	8,000	$61.63	142,484	No	4	S	Direct
Common Stock	Disposition	2018-01-16	52,000	$61.63	90,484	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	S	Direct
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct

Footnotes

The sale reported in this Form 4 is made pursuant to a Rule 10b5-1 trading plan.
The original Form 4, filed on January 16, 2018, is being amended by this Form 4 amendment solely to correct an administrative error, which misreported a sale that occurred on January 12, 2018 as a total of 5,000 shares sold when in fact 8,000 shares of the Issuer's common stock were sold. As a result of this administrative error, the number of shares beneficially owned by the reporting person following the corrected transaction reflects a reduction in the number of shares reported as beneficially owned by the reporting person by 3,000 shares, and includes shares acquired in dividend reinvestment transactions.
The exercise and sale transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan.